ArticlePediatric investigation2025
Guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection in children in China.
Article in Pediatric investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- New insight into the epidemiological trends of respiratory syncytial virus infection and the underlying anti-respiratory syncytial virus mechanisms of andrographolide: integrating Global Burden of Disease database, network pharmacological analysis, andMicrobiology spectrum · 2026Article
- A single-center observational study of nirsevimab for prevention of RSV infection in preterm infants.Frontiers in pediatrics · 2026Article
- Clinical efficacy of immunoglobulin in pediatric patients with severe respiratory syncytial virus pneumonia: a retrospective clinical analysis.Frontiers in medicine · 2026Article
- Guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection in children in China.Pediatric investigation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV-related diseases. To better guide and standardize the clinical diagnosis and treatment of RSV infection and to improve the prevention and control of RSV infection in children in China, a guideline development group was established by experts in children's respiratory infections and neonatal health care, clinical epidemiology, health statistics, virology, evidence-based medicine, health economics, and other related fields. Following the standard methodology for developing clinical practice guidelines, 12 clinical questions concerning the detection, diagnosis, treatment, and prevention of RSV infection were proposed from the perspective of clinical practice. Finally, the "Guideline for the diagnosis, treatment, and prevention of RSV infection in children in China" was formulated to improve the clinical diagnosis, treatment, prevention, and control of RSV infection-related diseases in children in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.